HONG KONG, Dec. 11 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (“CCBC” or “the Company”) (NYSE: CO - News), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its unaudited financial results for the quarter and six months ended September 30, 2009.
